Tumor Angiogenesis (Record no. 28458)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02046nam a22002537a 4500 |
| 001 - CONTROL NUMBER | |
| control field | 20240827105923.0 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | 20240827105923.0 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240827110244.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240827b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-3-319-33671-8 |
| International Standard Book Number | 978-3-319-33673-2 (eBook) |
| International Standard Book Number | 978-3-319-33672-5 (print and electronic bundle) |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | ddc |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | English |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Fuller form of name | Dieter Marmé |
| 245 ## - TITLE STATEMENT | |
| Title | Tumor Angiogenesis |
| Remainder of title | A Key Target for Cancer Therapy |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Freiburg, Baden-Württemberg, Germany : |
| Name of publisher, distributor, etc. | Springer Nature Switzerland AG : |
| Date of publication, distribution, etc. | 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 668 Pages |
| Extent | Includes References and Index |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | This is the first comprehensive book to cover all areas of a rapidly expanding research area. Each chapter is written by world experts in the field and topics covered include in vivo models, mechanisms, inhibition, and the role of macrophages, cytokines, proteases, extracellular matrix components, nitric oxide, prostanoids and oncogenes/tumour suppressor genes in angiogenesis. Other chapters examine the role of specific growth factors in angiogenesis, including vascular endothelial growth factor, the basic fibroblast growth factor family, transforming growth factor-beta, tumour necrosis factor-alpha, platelet-derived endothelial cell growth factor/thymidine phosphorylase and pleiotrophin and related molecules. Clinical issues are addressed in chapters that deal with the prognostic and predictive value of tumor microvessel density and the therapeutic significance of microregional blood flow. The two final chapters examine the feasibility of targeting tumour vasculature using either antibodies or gene therapy. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Medical / Oncology / General, Medical / Physiology, Science / Life Sciences / Cell Biology, Tumors -- Blood-vessels -- Growth, Vascular endothelial growth factors, Neovascularization, Neovascularization inhibitors |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1007/978-3-319-33673-2">https://doi.org/10.1007/978-3-319-33673-2</a> |
| Link text | https://doi.org/10.1007/978-3-319-33673-2 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | E-BOOKS |
| Suppress in OPAC | |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total checkouts | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 08/27/2024 | 20240827105923.0 | 08/27/2024 | 08/27/2024 | E-BOOKS |